Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites
Jessie Y. Li(Yale University), Gulden Menderes(Yale University), Levent Mutlu(Yale University), Wafa Khadraoui(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Natália Buza(Yale University), Pei Hui(First Affiliated Hospital of Zhengzhou University), Lingeng Lu(Yale Cancer Center), Nupur Nagarkatti(Yale University), Peter E. Schwartz(Yale University), Joan Tymon‐Rosario(Yale University)
Cited by 10
Related Papers
Type I and II Endometrial Cancers: Have They Different Risk Factors?
|Journal of Clinical Oncology|2013|833
High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
|Journal of Clinical Oncology|1993|353
H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase
|Nature Communications|2015|271